Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial comparing different surgical approaches for stage IA non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies [Phase 4]
Phase 4 clinical trial evaluating safety and quality of life in elderly patients with advanced/metastatic cancer undergoing immunotherapy ha…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg [Phase 2]
Phase 2 trial of Firmonertinib in EGFR-mutant advanced non-small cell lung cancer shows disease stabilization after an 8-week induction with…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study evaluating DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. The enrolled diseases include …
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A clinical trial update discusses safety and efficacy of combining APL-101 with frontline Osimertinib in patients with EGFR-mutated metastat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Induction Lorlatinib in Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating induction lorlatinib for Stage III non-small cell lung cancer, including patients undergoing surgery. The study i…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: easyEndoTM Powered in Thoracic Surgery [NA]
A clinical trial evaluating the easyEndoTM Powered in Thoracic Surgery for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI [Phase 1]
This Phase 1 trial investigating Functional Lung Avoidance Radiation Therapy using Hyperpolarized Xenon-129 MRI for non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients [Phase 1, Phase 2]
This is a clinical trial update describing a Phase 1/2 study of Roginolisib (IOA-244) in combination with Dostarlimab, with or without Docet…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk [NA]
A clinical trial update indicates lidocaine may reduce postoperative recurrence and metastasis risk in non-small cell lung cancer, though th…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations [Phase 1, Phase 2]
This update covers an ongoing Phase 1/2 study of amivantamab combined with tyrosine kinase inhibitors for advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Mobilization Before and After Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy
A completed clinical trial update examining mobilization before and after video-assisted thoracoscopic surgery lobectomy or segmentectomy fo…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC [Phase 2]
This clinical trial update reports on a Phase 2 study of the combination of nivolumab and ramucirumab in patients with recurrent, advanced, …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 trial evaluates adding osimertinib to chemotherapy versus chemotherapy with placebo in non-small cell lung cancer, with results po…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients
A completed clinical trial investigates whether pretreatment emotional distress affects survival in patients receiving immunotherapy. It als…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 [Phase 1]
This Phase 1 study assesses how BI-754111 is distributed in patients with advanced non-small cell lung cancer or head and neck cancer who ar…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated cabozantinib (XL184) with or without erlotinib in non-small cell lung cancer, and results hav…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation [Phase 1, Phase 2]
The Phase 1/2 study of JAB-21822 in adults with KRAS G12C-mutant advanced solid tumors, including non-small cell lung cancer and colorectal …
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) [Phase 2]
A Phase 2 trial evaluating 80 mg osimertinib in patients with non-small cell lung cancer has completed, reporting on efficacy and safety. Th…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating a first-line treatment regimen of trastuzumab deruxtecan, pembrolizumab, and platinum-based chem…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer [Phase 2]
Phase 2 study evaluating the combination of nivolumab and ipilimumab with circulating tumor DNA assessment in non-small cell lung cancer was…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating hybrid dose-fraction radiotherapy for metastatic non-small cell lung cancer has completed.